首页> 美国卫生研究院文献>Chronic Respiratory Disease >A long-term retrospective study of patients with biopsy-provencryptogenic organizing pneumonia
【2h】

A long-term retrospective study of patients with biopsy-provencryptogenic organizing pneumonia

机译:经活检证实的患者的长期回顾性研究隐源性组织性肺炎

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Cryptogenic organizing pneumonia (COP) is characterized by good response to corticosteroids, but frequent relapses after reduction or cessation of treatment are noted. The incidence, risk factors of relapse, and long-term outcomes of patients with COP remain undetermined. Patients with COP from September 2010 to December 2017 were enrolled. Hospital and office records were used as data sources. Clinical information, lab examinations, chest radiographs, treatment courses, and follow-up data were collected. Relapse group was defined as worsening of clinical manifestations in combination with progression of radiographic abnormalities in the absence of identified causes. Eighty-seven patients with COP were enrolled. Of them, 73 patients were treated with corticosteroids with relapse rate yielding 31.5% (23 of 73). Eleven patients were treated with macrolides and none of them relapsed. Fever was more common (65.2% vs. 32.0%, p = 0.004), C-reactive protein (CRP) was higher (31.5 ± 39.4 mg/L vs. 17.5 ± 32.2 mg/L, p = 0.038), and diffusion capacity for carbon monoxide (DLCO) % predicted was lower (45.9 ± 14.2% vs. 57.6 ± 18.5%, p = 0.050) in relapse group compared to nonrelapse group. Four patients who presented with organizing pneumonia (OP) asthe first manifestation were ultimately diagnosed with OP secondary toautoimmune disease in follow-up. We showed relapse was common in COP patientstreated with corticosteroids, but the prognosis was favorable. Fever, elevatedCRP, and a reduced DLCO were related to relapse. As OP may not always becryptogenic, a careful follow-up should be programmed to diagnose the underlyingsystemic disease.
机译:隐源性组织性肺炎(COP)的特征是对皮质类固醇的良好反应,但是在减少或停止治疗后,经常复发。 COP患者的发病率,复发风险因素和长期预后仍未确定。纳入2010年9月至2017年12月的COP患者。医院和办公室记录被用作数据源。收集了临床信息,实验室检查,胸部X光片,治疗过程和随访数据。复发组被定义为在没有确定原因的情况下,临床表现恶化并伴有影像学异常进展。入选了87例COP患者。其中,73例接受皮质类固醇激素治疗的患者复发率达31.5%(73例中的23例)。 11例患者接受大环内酯类药物治疗,均未复发。发烧更为常见(65.2%对32.0%,p = 0.004),C反应蛋白(CRP)较高(31.5±39.4 mg / L vs. 17.5±32.2 mg / L,p = 0.038)和扩散能力与非复发组相比,复发组中一氧化碳(DLCO)的预测百分比较低(45.9±14.2%比57.6±18.5%,p = 0.050)。四例出现组织性肺炎(OP)的患者最初的表现最终被诊断为继发于OP自身免疫性疾病的随访。我们显示COP患者复发很常见皮质类固醇激素治疗,但预后良好。发高烧CRP和DLCO降低与复发有关。由于OP可能并不总是具有隐源性,应进行仔细的随访以诊断潜在的全身性疾病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号